MicroRNA in breast cancer: The association with BRCA1/2

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Biomarkers

• Publication date

  2017-05-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.3233/CBM-160319PMID 28128741
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans.

  2017cited by this paper
• miR-155 expression level changes might be associated with initial phases of breast cancer pathogenesis and lymph-node metastasis

  2016cited by this paper
• Abstract A33: Expression of BRCA2 and Mir-21 in sporadic and BRCA2 mutated breast cancer in Iceland

  2016cited by this paper
• Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies.

  2016cited by this paper
• miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells

  2016cited by this paper
• Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer

  2016cited by this paper
• Re-evaluation of the roles of DROSHA, Exportin 5, and DICER in microRNA biogenesis

  2016cited by this paper
• miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development

  2016cited by this paper
• European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?

  2015cited by this paper
• Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers

  2015cited by this paper
• Post-transcriptional regulation of BRCA1 through its coding sequence by the miR-15/107 group of miRNAs

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Circulating cell-free miRNAs as biomarker for triple-negative breast cancer

  2015cited by this paper
• A new ensemble coevolution system for detecting HIV-1 protein coevolution

  2015cited by this paper
• The association of alcohol consumption with mammographic density in a multiethnic urban population

  2015cited by this paper
• Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer

  2015cited by this paper
• Breast cancer intrinsic subtype classification, clinical use and future trends.

  2015cited by this paper
• miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers

  2015influential reference
• MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer

  2015cited by this paper
• Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers

  2015influential reference
• Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A.

  2014cited by this paper
• Aberrant DNA methylation of microRNA genes in human breast cancer – a critical appraisal

  2014cited by this paper
• Expression of base excision repair key factors and miR17 in familial and sporadic breast cancer

  2014cited by this paper
• Stromal expression of miR-21 identifies high-risk group in triple-negative breast cancer.

  2014cited by this paper
• Mechanisms of miRNA-Mediated Gene Regulation from Common Downregulation to mRNA-Specific Upregulation

  2014cited by this paper
• New Strategies for Triple-Negative Breast Cancer—Deciphering the Heterogeneity

  2014cited by this paper
• European cancer mortality predictions for the year 2014.

  2014cited by this paper
• High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation

  2014cited by this paper
• MicroRNA expression signatures for the prediction of BRCA1/2 mutation‐associated hereditary breast cancer in paraffin‐embedded formalin‐fixed breast tumors

  2014cited by this paper
• Value of neutrophil lymphocyte ratio in patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib

  2014cited by this paper
• MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome

  2014cited by this paper
• miR‐342‐3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer

  2014cited by this paper
• Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2

  2014cited by this paper
• miR-638 mediated regulation of BRCA1affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer

  2014cited by this paper
• MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability

  2014cited by this paper
• miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer

  2014cited by this paper
• The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion

  2014cited by this paper
• Regulation of Breast Cancer and Bone Metastasis by MicroRNAs

  2013cited by this paper
• The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease

  2013cited by this paper
• The Role of MicroRNAs in Breast Cancer Migration, Invasion and Metastasis

  2012cited by this paper
• BRCA1 and MicroRNAs: Emerging networks and potential therapeutic targets

  2012cited by this paper
• European cancer mortality predictions for the year 2012.

  2012cited by this paper
• Posttranscriptional Upregulation by MicroRNAs

  2012cited by this paper
• Identification of a novel disease-associated variant in the BRCA1 3’UTR that introduces a functional miR-103 target site

  2012cited by this paper
• Up-regulation of miR-1245 by c-myc targets BRCA2 and impairs DNA repair.

  2012influential reference
• miRNA-Mediated Gene Silencing by Translational Repression Followed by mRNA Deadenylation and Decay

  2012cited by this paper
• Epigenetic control of an oncogenic microRNA, miR-155, by BRCA1

  2012cited by this paper
• Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway

  2012cited by this paper
• MicroRNA and cancer

  2012cited by this paper
• Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155

  2011cited by this paper
• MicroRNA and Cancer

  2011cited by this paper
• Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers

  2011influential reference
• miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors.

  2011cited by this paper
• A new role for miR-182 in DNA repair.

  2011cited by this paper
• miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans.

  2011cited by this paper
• Micro‐RNAs and breast cancer

  2010cited by this paper
• miR-15a and miR-16-1 in cancer: discovery, function and future perspectives

  2010cited by this paper
• Pathology of hereditary breast cancer.

  2010cited by this paper
• A MicroRNA targeting dicer for metastasis control.

  2010cited by this paper
• MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression

  2010cited by this paper
• MicroRNAs in breast cancer pathogenesis.

  2010cited by this paper
• Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients.

  2010influential reference
• MicroRNAs: synthesis, mechanism, function, and recent clinical trials.

  2010cited by this paper
• BRCA Gene Structure and Function in Tumor Suppression: A Repair-Centric Perspective

  2010influential reference
• BRCA1 affects global DNA methylation through regulation of DNMT1

  2010cited by this paper
• The docking protein and proto-oncogene product Gab2 is regulated via a novel negative feedback mechanism mediated by 14-3-3 binding

  2009cited by this paper
• Epithelial to mesenchymal transition and breast cancer

  2009cited by this paper
• Cell Communication and Signaling BioMed Central Review Regulation of MicroRNA Biogenesis: A miRiad of mechanisms

  2009cited by this paper
• Novel genetic variants in microRNA genes and familial breast cancer

  2009cited by this paper
• miR-155: On the Crosstalk Between Inflammation and Cancer

  2009cited by this paper
• Histological and molecular types of breast cancer: is there a unifying taxonomy?

  2009cited by this paper
• Epidemiology of basal-like breast cancer

  2008cited by this paper
• MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.

  2008cited by this paper
• A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.

  2008cited by this paper
• MicroRNAs (miRNAs) in Neurodegenerative Diseases

  2008cited by this paper
• How basal are triple‐negative breast cancers?

  2008cited by this paper
• BRCA1 dysfunction in sporadic basal-like breast cancer

  2007cited by this paper
• Stabilization of RAD51 nucleoprotein filaments by the C-terminal region of BRCA2

  2007cited by this paper
• Breast cancer: origins and evolution.

  2007cited by this paper
• miRNA: the new gene silencer.

  2007cited by this paper
• Leukocyte Reduction, Plasma Apheresis, and Cytomegalovirus DNA Levels in Samples

  2007cited by this paper
• Classification of ductal carcinoma in situ by gene expression profiling

  2006cited by this paper
• Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data

  2006cited by this paper
• microRNA target predictions in animals

  2006cited by this paper
• MicroRNAs: a new class of regulatory genes affecting metabolism.

  2006cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

  2005cited by this paper
• Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers

  2005cited by this paper
• MicroRNA biogenesis: coordinated cropping and dicing

  2005cited by this paper
• Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases.

  2005cited by this paper
• The Concept of Synthetic Lethality in the Context of Anticancer Therapy

  2005cited by this paper
• Hallmarks of 'BRCAness' in sporadic cancers

  2004cited by this paper
• Structural requirements for pre-microRNA binding and nuclear export by Exportin 5.

  2004cited by this paper
• Apoptotic versus genotoxic potential of anti-tumor agents: a concept of duality in unity.

  2003cited by this paper
• Cell cycle and genetic background dependence of the effect of loss of BRCA2 on ionizing radiation sensitivity

  2003cited by this paper
• Functional siRNAs and miRNAs exhibit strand bias.

  2003cited by this paper
• Insights into DNA recombination from the structure of a RAD51–BRCA2 complex

  2002cited by this paper
• Chromosomal breakage syndromes and the BRCA1 genome surveillance complex.

  2001cited by this paper
• Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer.

  2000cited by this paper
• The Pathology of Hereditary Breast Cancer

  1999cited by this paper

• A circulating microRNA-based diagnostic model for breast cancer, in which the miR-139-3p/RPA2 axis regulates the sensitivity to DNA-damaging agents

  2026cites this paper
• IL-3/STAT5/miR-155-5p axis supports stem-related pathway reprogramming in TNBC

  2025cites this paper
• Research Progress of Mitochondrial microRNAs in Tumorigenesi

  2025cites this paper
• Expanding Three-Coordinate Gold(I) Anticancer Agent Chemical Space.

  2025cites this paper
• Natural compounds and strategies for fighting against drug resistance in cancer: a special focus on phenolic compounds and microRNAs.

  2025cites this paper
• microRNAs as Biomarkers of Breast Cancer

  2025cites this paper
• The role of microRNAs in breast cancer: Diagnostic and therapeutic implications.

  2025cites this paper
• MicroRNA networks linked with BRCA1/2, PTEN, and common genes for Alzheimer's disease and breast cancer share highly enriched pathways that may unravel targets for the AD/BC comorbidity treatment

  2023cites this paper
• Melodic maestros: Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma.

  2023cites this paper
• Immunomodulatory effects of one novel microRNA miR-63 in pearl oyster Pinctada fucata martensii.

  2023cites this paper
• CircDENND2D Inhibits PD-L1-Mediated Non-Small Cell Lung Cancer Metastasis and Immune Escape by Regulating miR-130b-3p/STK11 Axis

  2023cites this paper
• Mitochondrial miRNAs (MitomiRs): Their Potential Roles in Breast and Other Cancers.

  2022cites this paper
• Cytotoxicity and Molecular Alterations Induced by Scorpion Venom Antimicrobial Peptide Smp43 in Breast Cancer Cell Lines MDA-MB-231 and MCF-7

  2022cites this paper
• Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer.

  2022cites this paper
• Circulating Exosomal microRNAs as Predictive Biomarkers of Neoadjuvant Chemotherapy Response in Breast Cancer

  2022cites this paper
• Prognostic Value of miR-1826 in Prostate Cancer and Its Regulatory Effect on Tumor Progression

  2021cites this paper
• Breast Cancer Response to Therapy: Can microRNAs Lead the Way?

  2021cites this paper
• MicroRNA-598 inhibits the growth of triple negative breast cancer cells by targeting JAG1

  2021cites this paper
• miR-93 regulates liver tumor initiating cells expansion and predicts chemotherapeutic response of patients.

  2021cites this paper
• Circulating microRNAs as Potential Non-invasive Biomarkers for Breast Cancer Detection

  2021cites this paper
• microRNA‐140‐3p modulates invasiveness, motility, and extracellular matrix adhesion of breast cancer cells by targeting syndecan‐4

  2021cites this paper
• CDX2 inducible microRNAs sustain colon cancer by targeting multiple DNA damage response pathway factors.

  2021cites this paper
• Regulatory MicroRNAs in T2DM and Breast Cancer

  2021cites this paper
• AC092127.1-miR-451a-AE binding protein 2 Signaling Facilitates Malignant Properties of Breast Cancer

  2021cites this paper
• miR-522 regulates cell proliferation, migration, invasion capacities and acts as a potential biomarker to predict prognosis in triple-negative breast cancer

  2021cites this paper
• Docosahexaenoic acid (DHA) and linoleic acid (LA) modulate the expression of breast cancer involved miRNAs in MDA-MB-231 cell line.

  2021cites this paper
• Analysis of inflammation-related microRNA expression in patients with ankylosing spondylitis

  2021cites this paper
• Deregulated Expression of Candidate MicroRNAs and BRCA Mutations Frequency in Breast Cancer Patients

  2021cites this paper
• OTT_A_295125 4467..4475

  2021cites this paper
• Protective effect of miR-146 against kidney injury in diabetic nephropathy rats through mediating the NF-κB signaling pathway.

  2021cites this paper
• Genetic profiling of breast cancer: A case study on Wnt and BRCA pathways

  2020cites this paper
• Nanocomplexes loaded with miR-128-3p for enhancing chemotherapy effect of colorectal cancer through dual-targeting silence the activity of PI3K/AKT and MEK/ERK pathway

  2020cites this paper
• MicroRNAs, DNA damage response and ageing

  2020cites this paper
• miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance

  2020cites this paper
• Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection

  2020cites this paper
• Protective effect of miR-146 against kidney injury in diabetic nephropathy rats through mediating the NF-κB signaling pathway.

  2020cites this paper
• MiR-186repressesproliferation, migration,invasionand EMTof hepatocellular carcinomavia directly targeting CDK6.

  2020cites this paper
• Circulating MicroRNAs as Prognostic and Therapeutic Biomarkers in Breast Cancer Molecular Subtypes

  2020cites this paper
• The Regulatory Role of Mitochondrial MicroRNAs (MitomiRs) in Breast Cancer: Translational Implications Present and Future

  2020cites this paper
• Aberrant expression of microRNA-132-3p and microRNA-146a-5p in Parkinson’s disease patients

  2020cites this paper
• Identification of colorectal cancers with defective DNA damage repair by immunohistochemical profiling of mismatch repair proteins, CDX2 and BRCA1

  2020cites this paper
• Association Between the miR-146a Rs2910164 Polymorphism and Childhood Acute Lymphoblastic Leukemia Susceptibility in an Asian Population

  2020cites this paper
• 3D And 2D RNA Structure Prediction Of The BRCA2 Gene And Its Silencing RNA In The Breast Cancer

  2020cites this paper
• MiR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer.

  2020cites this paper
• Current and future trends in diagnostics and treatment

  2020cites this paper
• Discovering regulatory non-coding RNA interactions (Düzenleyici kodlanmayan RNA etkileşimlerinin keşfi)

  2019cites this paper
• Tiny Yet Indispensable Plant MicroRNAs Are Worth to Explore as Key Components for Combating Genotoxic Stresses

  2019cites this paper
• Neoadjuvant therapy in breast cancer – objectives and tasks

  2019cites this paper
• Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1α

  2019cites this paper
• A genetic variant in miR‐100 is a protective factor of childhood acute lymphoblastic leukemia

  2019cites this paper
• MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1

  2019cites this paper
• MiR-214-3p regulates the viability, invasion, migration and EMT of TNBC cells by targeting ST6GAL1

  2019cites this paper
• Sensitive electrochemical detection of microRNA-21 based on propylamine-functionalized mesoporous silica with glucometer readout

  2018cites this paper
• Characterisation of infection associated microRNA and protein cargo in extracellular vesicles of Theileria annulata infected leukocytes

  2018cites this paper
• Effects of miRNAs on functions of breast cancer stem cells and treatment of breast cancer

  2018cites this paper
• BRCA1 mutation spectrum, functions, and therapeutic strategies: The story so far.

  2018cites this paper
• Discovering lncRNA mediated sponge interactions in breast cancer molecular subtypes

  2017cites this paper
• MiR-182 regulates proliferation and apoptosis by targeting FBW 7 in glioma cells

  2017cites this paper
• RUNX3 inhibits the proliferation and metastasis of gastric cancer through regulating miR-182/HOXA9.

  2017cites this paper